Can-Fite BioPharma (CANF) Interest Coverage Ratio (QoQ) (2014 - 2019)
Can-Fite BioPharma (CANF) Interest Coverage Ratio (QoQ) (2014 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Can-Fite BioPharma | 2.76 Mn | -8.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -259.67% |
| Sep 30, 2019 | -89.87% |
| Jun 30, 2019 | 303.26% |
| Mar 31, 2019 | 334.52% |
| Dec 31, 2018 | -286.05% |
| Sep 30, 2018 | -103.50% |
| Jun 30, 2018 | 263.04% |
| Mar 31, 2018 | -74.98% |
| Dec 31, 2017 | 162.59% |
| Sep 30, 2017 | -538.67% |
| Jun 30, 2017 | -73.07% |
| Mar 31, 2017 | 34.23% |
| Dec 31, 2016 | 360.78% |
| Sep 30, 2016 | 209.40% |
| Jun 30, 2016 | -310.73% |
| Mar 31, 2016 | 315.87% |
| Dec 31, 2015 | -284.30% |
| Sep 30, 2015 | -99.93% |
| Jun 30, 2015 | 392.46% |
| Sep 30, 2014 | -261.43% |